{
    "eu_pnumber": "EU/1/20/1492",
    "atc_code": "L01X",
    "eu_aut_status": "ACTIVE",
    "eu_brand_name_current": "Tecartus",
    "status_type": "a",
    "active_substance": "brexucabtagene autoleucel",
    "eu_mah_current": "Kite Pharma EU B.V.",
    "eu_orphan_con_current": [
        {
            "pre": "o",
            "id": "2220",
            "eu_num": "EU/3/19/2220",
            "indication": "Treatment of mantle cell lymphoma",
            "link_date": "2020-12-15"
        },
        {
            "pre": "o",
            "id": "2344",
            "eu_num": "EU/3/20/2344",
            "indication": "Treatment of acute lymphoblastic leukaemia",
            "link_date": "2022-09-05"
        }
    ],
    "orphan_status": "h",
    "eu_aut_date": "2020-12-14 00:00:00",
    "eu_aut_type_initial": "conditional",
    "eu_aut_type_current": "conditional",
    "ema_number": "EMEA/H/C/005102",
    "ema_number_id": "5102",
    "eu_referral": "False",
    "eu_suspension": "False",
    "ema_number_certainty": "0.9",
    "authorisation_row": "0",
    "scrape_date_web": "19/12/2022",
    "filedates": {}
}